Victory Capital Management Inc Ascendis Pharma A/S Transaction History
Victory Capital Management Inc
- $146 Billion
- Q2 2025
A detailed history of Victory Capital Management Inc transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Victory Capital Management Inc holds 219,118 shares of ASND stock, worth $42.9 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
219,118
Previous 124,926
75.4%
Holding current value
$42.9 Million
Previous $19.5 Million
94.24%
% of portfolio
0.03%
Previous 0.02%
Shares
23 transactions
Others Institutions Holding ASND
# of Institutions
274Shares Held
60MCall Options Held
217KPut Options Held
60.3K-
Ra Capital Management, L.P. Boston, MA10.3MShares$2.01 Billion38.78% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.48MShares$1.07 Billion4.42% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.98MShares$975 Million15.67% of portfolio
-
Janus Henderson Group PLC London, X04.43MShares$867 Million0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.26MShares$833 Million1.14% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $10.9B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...